Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac Tromethamine for CME Prophylaxis in Diabetic Phacoemulsification
NCT03551808Phase 2Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2017
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketorolac tromethamine in cystoid macular edema (CME), sponsored by Shahid Beheshti University of Medical Sciences. Status: unknown.
02
Drugs
ketorolac tromethamine
03
Conditions
cystoid macular edema (CME)
Beyond the preview
Go deeper on NCT03551808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03551808.